+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circassia Pharmaceuticals - logo

Circassia is a pharmaceutical company that innovates products for respiratory diseases. Circassia was established in 2006 in Morrisville, U.S. In March 2014 they completed an initial public offering on the London Stock Exchange.The product Tudorza is marketed by Circassia which is a product used to treat COPD chronic obstructive pulmonary disease.Circassia collaborates with Astra Zeneca which helps them promote Tudorza and it gives them rights to Duaklir® which has increased their sales majorly. Also in 2015, they completed acquisitions with Aerocrine and Prosonix which helps them to commercialize their products and broaden their pipelines.

From
From
Birch Pollen Allergy - Pipeline Insight, 2020 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 pages
From
Allergies Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Allergies Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • October 2018
  • 567 pages
From
From
Tudorza 2020 U.S. Promotional Audit Report - Product Thumbnail Image

Tudorza 2020 U.S. Promotional Audit Report

  • Report
  • July 2021
  • 25 pages
From
From
Tudorza Pressair - Product Thumbnail Image

Tudorza Pressair

  • Report
  • July 2018
  • 17 pages
From
Duaklir Pressair - Product Thumbnail Image

Duaklir Pressair

  • Report
  • July 2018
  • 18 pages
From
Loading Indicator
adroll